A first-in-class, first-in-human, phase I trial of p28, a non-HDM2-mediated peptide inhibitor of p53 ubiquitination in patients with advanced solid tumours
| Image |  |
|---|---|
| Description | scientific article published on 28 February 2013 |
| Author/s |
author: Craig W. Beattie |
| Publication date | February 28, 2013 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |